PharmaCyte Biotech Inc

PharmaCyte Biotech Inc is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States Their primary therapeutic areas include various forms of cancer diabetes and malignant ascites Central to their efforts is CellinaBox their proprietary encapsulation technology which utilizes cellulose to enclose live cells This innovative platform serves as the foundation for treatments aimed at diverse cancers such as advanced and inoperable pancreatic cancer as well as diabetes The companys pipeline includes therapies for pancreatic and other solid cancerous tumors a treatment for Type 1 and insulindependent Type 2 diabetes involving encapsulated genetically modified insulinproducing cells and cancer treatments derived from cannabis plant compounds To further its research PharmaCyte maintains collaborative agreements one with the University of Technology Sydney for the creation of melligen cells to combat diabetes and another with the University of Northern Colorado focusing on methods for identifying separating and quantifying cannabis constituents Originally established in 1996 the company operated under the name Nuvilex Inc before rebranding as PharmaCyte Biotech Inc in January 2015 Its corporate headquarters are located in Las Vegas Nevada